REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
09/03/2026
Voltar para busca
Dado oficial do USPTO
CBCB-METHOD
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
CBCB-METHOD
ST13
US500000088404956Classe
1, 5, 42
Pedido
88404956
Registro
6285669
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
28
Atualização mais recente
10/03/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42
Data de depósito
26/04/2019
Data de registro
09/03/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
09/03/2021
Última transação
10/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Foreign priority
Código do desenho
4
Tipo de titular
27
Localização do titular
BERLIN, DE
Examinador
DICKSON, RACHAEL
Unidade examinadora
N70
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
SYNBIONIK GMBH
Farmako GmbH
Representantes
Devasena Reddy HM LAW GROUP LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
chemical preparations for industrial and scientific use; biological preparations for industrial and scientific useall the aforesaid goods are for use only with non-consumablenon-medicinalnon-therapeutic goods derived solely from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis
Classe 5
Fungicidesherbicidesantibacterial; flour for pharmaceutical purposes; analgesics; local analgesics; antipyretic analgesics; anti-inflammatory pain patches; analgesic creams; analgesics; universal medical pain-relieving creams; Analgesic pharmaceutical effervescent preparations; Pharmaceutical preparations and substances with analgesic properties; Laxatives; Laxative tablets; Antibiotics; Antiseptics; Veterinary medicinal productsveterinary vaccines; Bath salts for medical purposes; Bath additives in the nature of bath salts for medical purposes; tree bark for pharmaceutical purposes for the treatment of gout; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; biological preparations for medical purposes for the treatment of cancer; biological preparations for veterinary purposesveterinary vaccines; Dietary foods for medical purposes; protein supplement preparations for medical purposes; enzymes for medical purposes; enzyme preparations for medical purposes; fats for medical purposes; freeze-dried foodstuffs for medical purposes; homogenised foodstuffs for medical purposes; allergy and diet capsules for medical purposes; allergy and diet capsules for pharmaceutical purposes; chewing gum for medical purposes; mineral waters for medical purposes; mineral water salts for medicinal purposes; wipes soaked with pharmaceutical lotions; mouthwashes for medical purposes; food supplements; Nerve-attenuating pharmaceutical preparations; therapeutic medicated bath preparations; all the aforesaid goods not containing any cannabishemp or CBD
Classe 42
pharmaceutical research services of a development and research company in the fields of biotechnologypharmacymedicinediagnostics and chemistry and information technology; productiondevelopment of biotechnologicalpharmaceutical and diagnostic processes and products; Development of processes for the production of chemical substances; chemical laboratory services; chemical technical consultancy; scientific and technological services and research and related design services in the field of pharmaceuticals; industrial analysis and research services to assure compliance with industry standards; design and development of computer software; development of pharmaceutical test methods; product design and development; development of industrial products; pharmaceutical research and development services; development of industrial engineering processes; scientific research and development; industrial pharmaceutical drug development servicesaforesaid services are for use only with non-consumablenon-medicinalnon-therapeutic goods derived solely from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis
Publicações
Histórico de despachos e eventos da marca no USPTO.
28 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
15/04/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
15/04/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
15/04/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
09/03/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
22/12/2020
PUBO
PUBLISHED FOR OPPOSITION
22/12/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/12/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
19/11/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
19/11/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
19/11/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
19/11/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
19/11/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
11/11/2020
GNSL
LETTER OF SUSPENSION E-MAILED
11/11/2020
CNSL
SUSPENSION LETTER WRITTEN
11/11/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
19/10/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
19/10/2020
ALIE
ASSIGNED TO LIE
19/10/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/09/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
28/04/2020
GNRT
NON-FINAL ACTION E-MAILED
28/04/2020
CNRT
NON-FINAL ACTION WRITTEN
28/04/2020
DOCK
ASSIGNED TO EXAMINER
16/04/2020
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
27/11/2019
DOCK
ASSIGNED TO EXAMINER
14/05/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
14/05/2019
NWAP
NEW APPLICATION ENTERED
30/04/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CBCB-METHOD ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.